Serina Therapeutics, Inc. (SER): Cash & Equivalents
$3.06M
As of 2025-12-31
$23.02M
As of 2026-06-30
+68.0%
3-year compound annual growth
+42.1%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.06M | -16.8% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $3.67M | -51.8% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $7.62M | n/m | 2025-03-24, Balance as of period end |
| 2022-12-31 | $645.0K | +10.4% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $584.0K | +10.8% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $527.0K | -77.6% | 2022-03-29, Balance as of period end |
| 2019-12-31 | $2.35M | -64.9% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $6.71M | -9.1% | 2020-03-31, Balance as of period end |
| 2017-12-31 | $7.38M | n/a | 2019-04-01, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $3.06M | -16.8% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.18M | -59.8% |
| iBio, Inc. (IBIO) | 2026-06-30 | $56.40M | +557.1% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $15.96M | -1.6% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $48.00M | -34.2% |
| Clene Inc. (CLNN) | 2025-12-31 | $5.19M | -57.3% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $69.6K | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
Compare SER, BFRG, IBIO, LSTA side by side · Screen every company in Pharmaceutical Preparations ↗